UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition. (UCLA Health)Why does this persist?
Read the entire column at NCPA's Health Policy Blog.
No comments:
Post a Comment